Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 31Unknown 18Recruiting 16Active not recruiting 9Terminated 7Not yet recruiting 4Withdrawn 3

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 4Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 471Neoplasms 328Colorectal Neoplasms 235Carcinoma, Non-Small-Cell Lung 234Lung Neoplasms 200Prostatic Neoplasms 179Carcinoma, Hepatocellular 174Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 114Uterine Cervical Neoplasms 110Rectal Neoplasms 105Multiple Myeloma 94Recurrence 89Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 79Neoplasm Metastasis 76Ovarian Neoplasms 75Brain Neoplasms 71Colonic Neoplasms 68Glioblastoma 67Esophageal Neoplasms 66Triple Negative Breast Neoplasms 65Endometrial Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Small Cell Lung Carcinoma 54Disease 54Motor Activity 53Hematologic Neoplasms 53Glioma 48

Interventions

Tissue Banks 1Drug Therapy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Urologic Neoplasms × Clear all
NCT07252882 2025-11-28

UUTICaD

University Hospital, Toulouse

Phase NA Not yet recruiting
178 enrolled
Genitourinary

Urologic Neoplasms

NCT07216456 2025-10-15

Vaginal Dilator Therapy After Pelvic Radiation

Duke University

Phase NA Not yet recruiting
88 enrolled
GenitourinaryGynecologic

Pelvic Neoplasms, Urologic Neoplasms

NCT06827639 2025-02-14

FUTURE

Assistance Publique Hopitaux De Marseille

Not yet recruiting
640 enrolled
BreastGastrointestinalGenitourinaryHead & NeckLymphoidOther hematologic neoplasmThoracic

Breast Neoplasms, Head and Neck Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Stomach Neoplasms, Urologic Neoplasms

NCT06427057 2024-05-23

A Study of Cadonilimab(AK104)Combined With Standard Treatment for Function Preservation in Urinary System Tumors

Tongji Hospital

Phase 2 Not yet recruiting
40 enrolled
Genitourinary

Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡